The role of uric acid in metabolic syndrome in patients with psoriasis
Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2017, Vol 51, Issue 2
Abstract
Background and Design: Psoriasis patients have increased risk of obesity, metabolic syndrome and cardiovascular disease. Uric acid is a metabolic marker associated with metabolic syndrome and cardiovascular diseases. Uric acid levels increase in psoriasis as well. The aim of this study was to investigate the role of uric acid in metabolic syndrome in patients with psoriasis. Materials and Methods: Chronic plaque psoriasis patients who presented to the dermatology outpatient clinics in a university-affiliated training and research hospital and age- and gender-matched healthy individuals were included in the study. Waist circumference, height and weight measurements in both groups were recorded, and body mass index was calculated. Serum uric acid, urea, creatinine, C-reactive protein, fasting blood glucose, high-density lipoprotein cholesterol, total cholesterol, triglyceride and insulin levels were determined. Metabolic syndrome and insulin resistance status were evaluated. The findings were compared statistically. Results: Seventy patients with chronic plaque psoriasis (37 females, 33 males) and 60 healthy individuals (31 females, 29 males) were included in the study. The prevalence of metabolic syndrome and uric acid levels were found to be higher in the psoriasis group than in control group (p=0.003 and p=0.008, respectively). Serum uric acid levels and Psoriasis Area and Severity Index scores were higher in psoriasis patients with metabolic syndrome than in those without metabolic syndrome when psoriasis patients were evaluated separately (p=0.041, p=0.024, respectively). A positive correlation was observed between abdominal circumference and serum uric acid levels in psoriasis patients (p=0.003, r=0.350 Conclusion: The results of this study show that uric acid levels are elevated in psoriasis patients with metabolic syndrome. The prevalence of metabolic syndrome was also significantly higher. Hence, patients should be followed up for development of uric acid-related disorders.
Authors and Affiliations
Berna Solak, Bahar Sevimli Dikicier, Teoman Erdem
Keywords
Related Articles
- EP ID EP364963
- DOI 10.4274/turkderm.55265
- Views 75
- Downloads 0
Melkersson-Rosenthal syndrome and psoriasis: An association beyond coincidence?
.
A case of lichen sclerosus et atrophicus on the scalp with unusual localization
.
Have you ever seen a pathologist with acne vulgaris?
empty
Is hyaluronidase injection effective in treating tear trough hyaluronic acid filler deformity?
.
Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia
Background and Design: Ischemia-modified albumin (IMA) is a biomarker, which is an indicator of ischemia and oxidative stress, and measured by the albumin cobalt binding test. Androgenetic alopecia (AGA) is the most impo...